Jay S Skyler


  • 12345 Citations
1968 …2023
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Jay S Skyler is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 8 Similar Profiles
Type 1 Diabetes Mellitus Medicine & Life Sciences
Insulin Medicine & Life Sciences
Diabetes Mellitus Medicine & Life Sciences
Blood Glucose Medicine & Life Sciences
C-Peptide Medicine & Life Sciences
Glucose Medicine & Life Sciences
Type 2 Diabetes Mellitus Medicine & Life Sciences
Glucose Tolerance Test Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 1985 2023

Type 1 Diabetes Mellitus
Regulatory T-Lymphocytes

Type 1 Diabetes TrialNet

Skyler, J. S.

National Institutes of Health


Project: Research project

Type 1 Diabetes Mellitus
Natural History
Islets of Langerhans
Clinical Trials
Type 1 Diabetes Mellitus
Prediabetic State
Research Personnel
Prodromal Symptoms


Skyler, J. S., Ironson, G., Kumar, M., Saab, P., Llabre, M., Schneiderman, N., Hurwitz, B., Goldberg, R. B., Nagel, J., Gerace, T., Schnederman, N., Mc Cabe, P., McCabe, P. & Skylar, J.

National Institutes of Health


Project: Research project

Ambulatory Monitoring
Blood Pressure
Heart Rate
Islets of Langerhans
Type 1 Diabetes Mellitus
Diabetes Mellitus

Research Output 1968 2019

25 Citations (Scopus)

An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes

Herold, K. C., Bundy, B. N., Alice Long, S., Bluestone, J. A., DiMeglio, L. A., Dufort, M. J., Gitelman, S. E., Gottlieb, P. A., Krischer, J. P., Linsley, P. S., Marks, J. B., Moore, W., Moran, A., Rodriguez, H., Russell, W. E., Schatz, D., Skyler, J. S., Tsalikian, E., Wherrett, D. K., Ziegler, A. G. & 1 others, Greenbaum, C. J., Aug 15 2019, In : New England Journal of Medicine. 381, 7, p. 603-613 11 p.

Research output: Contribution to journalArticle

Type 1 Diabetes Mellitus
Anti-Idiotypic Antibodies
HLA-DR3 Antigen

Associations of HbA1c with the timing of C-peptide responses during the oral glucose tolerance test at the diagnosis of type 1 diabetes

Type 1 Diabetes Trial Net and Diabetes Prevention Trial-Type-1 (DPT-1) Study Groups, Jun 1 2019, In : Pediatric Diabetes. 20, 4, p. 408-413 6 p.

Research output: Contribution to journalArticle

Glucose Tolerance Test
Type 1 Diabetes Mellitus
Area Under Curve

Bringing closure: towards achieving a better understanding of Israel

Rosenstock, J., Zimmet, P., Skyler, J. S., Atkinson, M., Schatz, D., Buse, J. B., Kahn, S., Hirsch, I. B., Leroith, D. & Alberti, K. G., Aug 17 2019, In : The Lancet. 394, 10198, 1 p.

Research output: Contribution to journalLetter

Open Access
1 Citation (Scopus)

Exploring patient preferences for adjunct-to-insulin therapy in type 1 diabetes

Perkins, B. A., Rosenstock, J., Skyler, J. S., Laffel, L. M., Cherney, D. Z., Mathieu, C., Pang, C., Wood, R., Kinduryte, O., George, J. T., Marquard, J. & Soleymanlou, N., Sep 1 2019, In : Diabetes care. 42, 9, p. 1716-1723 8 p.

Research output: Contribution to journalArticle

Sodium-Glucose Transport Proteins
Patient Preference
Type 1 Diabetes Mellitus

Imagining a better future for all people with type 1 diabetes mellitus

Korsgren, O., Skyler, J. S., Skog, O., Sundberg, F., Forsander, G. & Ludvigsson, J., Jan 1 2019, (Accepted/In press) In : Nature Reviews Endocrinology.

Research output: Contribution to journalComment/debate

Type 1 Diabetes Mellitus